Results 151 to 160 of about 6,173,924 (311)

Individual Investor Mutual-Fund Flows [PDF]

This paper studies the relation between individuals' mutual fund flows and fund characteristics, establishing three key results. First, consistent with tax motivations, individual investors are reluctant to sell mutual funds that have appreciated in ...
Scott Weisbenner, Zoran Ivkovich
core  

The impact of the global budget payment on healthcare fund expenditure in integrated delivery systems: evidence from China's county-level medical alliance reform. [PDF]

Front Public Health
Wu K, Wang X.
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Annual report of the Client Security Fund Committee. 2008.

, 2009
Annual; Began in 2006?; "Pursuant to Practice Book [section] 2-72(e), the following is a report of claims filed with the Client Security Fund Committee during calendar year ..., and on the Committee's activities during ... in connection with claims filed
Connecticut. Client Security Fund Committee.
core  

Explainable Plasma Proteomics-Based Machine Learning for Osteoporosis Diagnosis, Prognosis, and Protein Biomarker Discovery in the UK Biobank. [PDF]

FASEB J
Zhang W, Zhang W, Cheng H, Gong W, Kou Y, Jiang B.   +5 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

High prevalence of magnesium supplementation during pregnancy: results from the LIFE Child study. [PDF]

Arch Gynecol Obstet
Neininger MP, Bremer SUJ, Dathan-Stumpf A, Stepan H, Kiess W, Bertsche A, Vogel M, Bertsche T.   +7 more
europepmc   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

Molecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens, Anouk Mentink, Tom Niessink, Frank Coumans, Leonie Mekenkamp, Ruchi Bansal, Jeroen Hiltermann   +6 more
wiley   +1 more source

Annual report of the Client Security Fund Committee. 2013.

, 2014
Annual; Began in 2006?; "Pursuant to Practice Book [section] 2-72(e), the following is a report of claims filed with the Client Security Fund Committee during calendar year ..., and on the Committee's activities during ... in connection with claims filed
Connecticut. Client Security Fund Committee.
core  

Maternal Influenza Vaccine Reduces the Risk of Respiratory Syncytial Virus and Related Respiratory Hospitalizations in Early Infancy: An Epidemiological Study. [PDF]

Clin Infect Dis
Holland C, Le H, Levy A, Minney-Smith C, Sarna M, Moore HC.   +5 more
europepmc   +1 more source